PMVP
PMV Pharmaceuticals, Inc.
There isn't enough reported data to score PMVP yet.
PMVP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
PMVP's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
PMVP PE Valuation
PMVP has no meaningful PE right now: it lost money over the past year.
PMVP Forward outlook
There aren't enough analyst estimates for PMVP to show an outlook.
PMVP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.53 | +$0.07 |
| Q2 2026 | -$1.41 | +$0.16 |
| Q1 2026 | -$1.48 | -$0.30 |
| Q4 2025 | -$1.48 | -$0.34 |
| Q3 2025 | -$1.60 | -$0.61 |
| Q2 2025 | -$1.57 | -$0.61 |
| Q1 2025 | -$1.18 | +$0.14 |
| Q4 2024 | -$1.14 | +$0.30 |
PMVP is still losing money, but less than at its worst: $1.53 per share over the past year, against $2.11 at its worst in late 2020.
PMVP Quarterly Revenue
PMVP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$18.2M | +$1.6M |
| Q2 2026 | -$14.6M | +$3.7M |
| Q1 2026 | -$19.7M | -$1.4M |
| Q4 2025 | -$17.2M | -$487K |
| Q3 2025 | -$19.8M | -$3M |
| Q2 2025 | -$18.3M | -$16.7M |
| Q1 2025 | -$18.3M | -$1.5M |
| Q4 2024 | -$16.7M | -$4.4M |
PMVP has burned cash in almost every quarter: −$70M over the past year, against −$73M the year before.
PMVP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +24% | +12.8M shares |
| 1 year | +25% | +13.2M shares |
| 3 years | +35% | +17.2M shares |
| 5 years | +46% | +20.9M shares |
| Available history | +112% | +35M shares |
PMVP has 66M diluted shares, up 25% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
PMVP Net Leverage
PMVP's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PMVP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.6 | Neutral |
| Stochastic | 23.3 | Neutral |
PMVP's weekly RSI is 47 (neutral) and its Stochastic is 23 (neutral).
PMVP PE vs Healthcare Sector
PMVP has no meaningful PE right now: it lost money over the past year.
PMVP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.36 | 11% below |
| 20 week MA | $1.31 | 7.6% below |
| 50 week MA | $1.29 | 6.2% below |
| 100 week MA | $1.28 | 5.5% below |
| 200 week MA | $2.39 | 49% below |
PMVP is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
PMVP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.5 | $55.6 | +48% |
| 2021 | $55.6 | $23.5 | -58% |
| 2022 | $23.5 | $8.73 | -63% |
| 2023 | $8.73 | $3.10 | -64% |
| 2024 | $3.10 | $1.50 | -52% |
| 2025 | $1.50 | $1.24 | -17% |
| 2026 YTD | $1.24 | $1.21 | -2.4% |
PMVP has finished five years in a row lower, and it's down 2.4% so far in 2026.